Showing results (271-280 of 319) with videos related to

Sort By:
Pageof 32
Biomolecules|July 2, 2021
DDR1 Affects Metabolic Reprogramming in Breast Cancer Cells by Cross-Talking to the Insulin/IGF SystemVeronica Vella, Marika Giuliano, Maria Luisa Nicolosi, et al.
Science Translational Medicine|January 31, 2020
Preclinical efficacy of the GPER-selective agonist G-1 in mouse models of obesity and diabetesGeetanjali Sharma, Chelin Hu, Daniela I Staquicini, et al.
ACS Chemical Biology|May 22, 2010
Influence of charge on cell permeability and tumor imaging of GPR30-targeted 111in-labeled nonsteroidal imaging agentsTapan K Nayak, Megan K Dennis, Chinnasamy Ramesh, et al.
Cells|November 15, 2018
miR-338-3p Is Regulated by Estrogens through GPER in Breast Cancer Cells and Cancer-Associated Fibroblasts (CAFs)Adele Vivacqua, Anna Sebastiani, Anna Maria Miglietta, et al.
Gynecologic Oncology|June 9, 2009
GPR30 predicts poor survival for ovarian cancerHarriet O Smith, Hugo Arias-Pulido, Dennis Y Kuo, et al.
Journal of Experimental & Clinical Cancer Research : CR|February 8, 2019
Focal adhesion kinase (FAK) activation by estrogens involves GPER in triple-negative breast cancer cellsDamiano Cosimo Rigiracciolo, Maria Francesca Santolla, Rosamaria Lappano, et al.
Scientific Reports|January 24, 2023
Identification of a human estrogen receptor α tetrapeptidic fragment with dual antiproliferative and anti-nociceptive actionBaptiste Jouffre, Alexandre Acramel, Mathilde Belnou, et al.
Journal of Cellular Physiology|September 9, 2016
Protective Role of GPER Agonist G-1 on Cardiotoxicity Induced by DoxorubicinErnestina M De Francesco, Carmine Rocca, Francesco Scavello, et al.
Pageof 32